Sareum Holdings plc (AIM:SAR)
London · Delayed Price · Currency is GBP · Price in GBX 22.00
+1.00 (4.76%)
Jul 6, 2026, 4:12 PM GMT
Sareum Holdings Market Cap
Sareum Holdings has a market cap or net worth of 29.1 million as of July 6, 2026. Its market cap has increased by 51.92% in one year.
Market Cap
29.10M
Enterprise Value
26.61M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
22.00
Market Cap Chart
Since December 6, 2004, Sareum Holdings's market cap has increased from 8.69M to 29.10M, an increase of 234.71%. That is a compound annual growth rate of 5.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 29.10M | 40.51% |
| Dec 31, 2025 | 20.71M | -32.34% |
| Dec 31, 2024 | 30.61M | -26.79% |
| Dec 29, 2023 | 41.81M | -25.56% |
| Dec 30, 2022 | 56.16M | -66.33% |
| Dec 31, 2021 | 166.77M | 110.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hemogenyx Pharmaceuticals | 52.36M |
| hVIVO | 49.12M |
| Poolbeg Pharma | 48.30M |
| SkinBioTherapeutics | 27.21M |
| Arecor Therapeutics | 23.98M |
| ImmuPharma | 21.68M |
| IXICO | 17.99M |
| Aptamer Group | 16.41M |